{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:38:09Z","timestamp":1791045489753,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1066128"],"award-info":[{"award-number":["APP1066128"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12890-019-0846-2","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T12:04:18Z","timestamp":1556885058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-2729","authenticated-orcid":false,"given":"Helen E.","family":"Jo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamera J.","family":"Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Glaspole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Grainge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M. A.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuben","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Haydn","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Zappala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Keir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle M.","family":"Mahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Macansh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole S.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"846_CR1","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW. Group AS. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083\u201392.","journal-title":"N Engl J Med"},{"key":"846_CR2","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR, Investigators IT. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071\u201382.","journal-title":"N Engl J Med"},{"key":"846_CR3","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/ajrccm.164.7.2003140","volume":"164","author":"T King","year":"2001","unstructured":"King T, Tooze J, Schwarz M, Brown K, Cherniack R. Predicting survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;164:1171\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"846_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1183\/09031936.06.00037005","volume":"27","author":"G Raghu","year":"2006","unstructured":"Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE, Pellegrini CA. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27:136\u201342.","journal-title":"Eur Respir J"},{"key":"846_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1164\/rccm.201104-0668OC","volume":"184","author":"DJ Lamas","year":"2011","unstructured":"Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med. 2011;184:842\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"846_CR6","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00101212","volume":"42","author":"E Savarino","year":"2013","unstructured":"Savarino E, Carbone R, Marabotto E, Furnari M, Sconfienza L, Ghio M, Zentilin P, Savarino V. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J. 2013;42:1322\u201331.","journal-title":"Eur Respir J"},{"key":"846_CR7","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1164\/ajrccm.158.6.9804105","volume":"158","author":"RW Tobin","year":"1998","unstructured":"Tobin RW, Pope CE, Pellegrini CA, Emond MJ, Sillery JIM, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;158:1804\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"846_CR8","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1164\/rccm.201101-0138OC","volume":"184","author":"JS Lee","year":"2011","unstructured":"Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE Jr, Collard HR. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184:1390\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"846_CR9","doi-asserted-by":"publisher","first-page":"e0151425","DOI":"10.1371\/journal.pone.0151425","volume":"11","author":"M Kreuter","year":"2016","unstructured":"Kreuter M, Ehlers-Tenenbaum S, Palmowski K, Bruhwyler J, Oltmanns U, Muley T, Heussel CP, Warth A, Kolb M, Herth FJ. Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS One. 2016;11:e0151425.","journal-title":"PLoS One"},{"key":"846_CR10","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1056\/NEJMcp0804684","volume":"359","author":"PJ Kahrilas","year":"2008","unstructured":"Kahrilas PJ. Gastroesophageal reflux disease. N Engl J Med. 2008;359:1700\u20137.","journal-title":"N Engl J Med"},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrgastro.2017.130","volume":"14","author":"E Savarino","year":"2017","unstructured":"Savarino E, Bredenoord AJ, Fox M, Pandolfino JE, Roman S, Gyawali CP, On behalf of the international working Group for Disorders of gastrointestinal M, function. Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol. 2017;14:665.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"846_CR12","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","volume":"129","author":"J Ronkainen","year":"2005","unstructured":"Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agreus L. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825\u201331.","journal-title":"Gastroenterology."},{"key":"846_CR13","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","volume":"192","author":"G Raghu","year":"2015","unstructured":"Raghu G, Rochwerg B, Zhang Y, Garcia CAC, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, Hoogsteden H, Sch\u00fcnemann HJ. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3\u2013e19.","journal-title":"Am J Respir Crit Care Med"},{"key":"846_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S2213-2600(13)70105-X","volume":"1","author":"JS Lee","year":"2013","unstructured":"Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med. 2013;1:369\u201376.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"846_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S2213-2600(16)00067-9","volume":"4","author":"M Kreuter","year":"2016","unstructured":"Kreuter M, Wuyts W, Renzoni E, Koschel D, Maher TM, Kolb M, Weycker D, Spagnolo P, Kirchgaessler K-U, Herth FJF, Costabel U. Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. Lancet Respir Med. 2016;4(5):381\u20139.","journal-title":"Lancet Respir Med"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000468546","volume":"93","author":"M Kreuter","year":"2017","unstructured":"Kreuter M, Spagnolo P, Wuyts W, Renzoni E, Koschel D, Bonella F, Maher TM, Kolb M, Weycker D, Kirchg\u00e4ssler K-U, Costabel U. Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis who received Pirfenidone. Respiration. 2017;93:415\u201323.","journal-title":"Respiration"},{"key":"846_CR17","doi-asserted-by":"crossref","unstructured":"Raghu G, Crestani B, Bailes Z, Schlenker-Herceg R, Costabel U. Effect of anti-acid medication on reduction in FVC decline with nintedanib. Eur Respir J. 2015;46.","DOI":"10.1183\/13993003.congress-2015.OA4502"},{"key":"846_CR18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00535-004-1417-7","volume":"39","author":"M Kusano","year":"2004","unstructured":"Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K, Horikoshi T, Sugiyama T, Toki M, Ohwada T, Mori M. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888\u201391.","journal-title":"J Gastroenterol"},{"key":"846_CR19","doi-asserted-by":"crossref","unstructured":"Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PM, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Keir GJ, Hayen A, Cooper WA, Mahar AM, Ellis S, Macansh S, Corte TJ. Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian idiopathic pulmonary fibrosis registry. Eur Respir J. 2017;49.","DOI":"10.1183\/13993003.01592-2016"},{"issue":"6","key":"846_CR20","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.chest.2018.03.008","volume":"153","author":"L Fidler","year":"2018","unstructured":"Fidler L, Sitzer N, Shapera S, Shah PS. Treatment of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Chest. 2018;153(6):1405\u201315.","journal-title":"Chest."},{"issue":"3","key":"846_CR21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.5056\/jnm15192","volume":"22","author":"CM Lee","year":"2016","unstructured":"Lee CM, Lee DH, Ahn BK, Hwang JJ, Yoon H, Shin CM, Park YS, Kim N. Protective effect of proton pump inhibitor for survival in patients with gastroesophageal reflux disease and idiopathic pulmonary fibrosis. J Neurogastroenterol Motil. 2016;22(3):444\u201351.","journal-title":"J Neurogastroenterol Motil"},{"key":"846_CR22","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3181\/0801-RM-17","volume":"233","author":"TE Downing","year":"2008","unstructured":"Downing TE, Sporn TA, Bollinger RR, Davis RD, Parker W, Lin SS. Pulmonary histopathology in an experimental model of chronic aspiration is independent of acidity. Exp biol med (Maywood, NJ). 2008;233:1202\u201312.","journal-title":"Exp biol med (Maywood, NJ)"},{"key":"846_CR23","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/ALN.0b013e318173f64f","volume":"108","author":"M Amigoni","year":"2008","unstructured":"Amigoni M, Bellani G, Scanziani M, Masson S, Bertoli E, Radaelli E, Patroniti N, Di Lelio A, Pesenti A, Latini R. Lung injury and recovery in a murine model of unilateral acid aspiration: functional, biochemical, and morphologic characterization. Anesthesiology. 2008;108:1037\u201346.","journal-title":"Anesthesiology."},{"key":"846_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1465-9921-8-87","volume":"8","author":"JZ Appel","year":"2007","unstructured":"Appel JZ, Lee SM, Hartwig MG, Li B, Hsieh C-C, Cantu E, Yoon Y, Lin SS, Parker W, Davis RD. Characterization of the innate immune response to chronic aspiration in a novel rodent model. Respir Res. 2007;8:87.","journal-title":"Respir Res"},{"issue":"9","key":"846_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S2213-2600(18)30301-1","volume":"6","author":"Ganesh Raghu","year":"2018","unstructured":"Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters PJ, Yates R, Anstrom KJ, Collard HR. Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial. Lancet Respir Med. 2018;6(9):707\u2013714.","journal-title":"The Lancet Respiratory Medicine"},{"issue":"1","key":"846_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.chest.2018.07.038","volume":"155","author":"David B\u00e9dard M\u00e9thot","year":"2019","unstructured":"B\u00e9dard M\u00e9thot D, Leblanc \u00c9, Lacasse Y. Meta-analysis of gastroesophageal reflux disease and idiopathic pulmonary fibrosis. Chest. 2019;155(1):33\u201343. \n                    https:\/\/doi.org\/10.1016\/j.chest.2018.07.038\n                    \n                  .","journal-title":"Chest"},{"key":"846_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ajg.2012.444","volume":"108","author":"PO Katz","year":"2013","unstructured":"Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308\u201328 quiz 29.","journal-title":"Am J Gastroenterol"},{"key":"846_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S2213-2600(17)30219-9","volume":"5","author":"KA Johannson","year":"2017","unstructured":"Johannson KA, Str\u00e2mbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M, Albera C, Antoniou KM, Altinisik G, Bendstrup E, Bondue B, Borie R, Brown KK, Camus P, Castillo D, Collard HR, Cottin V, Crimi N, Ferrara G, Fischer A, Gauldie J, Geiser T, Guenther A, Hambly N, Hansell DM, Harari S, Jones MG, Keane M, Ley B, Maher TM, Molina-Molina M, Palmucci S, Poletti V, Prasse A, Rottoli P, Spagnolo P, Sterclova M, Torrisi S, Tsitoura E, Vasakova M, Walsh SL, Wijsenbeek MS, Wuyts WA. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? Lancet Respir Med. 2017;5:591\u20138.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"846_CR29","doi-asserted-by":"publisher","first-page":"1800376","DOI":"10.1183\/13993003.00376-2018","volume":"51","author":"Tanja Tran","year":"2018","unstructured":"Tran T, Suissa S. The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies. Eur Respir J. 2018;51.","journal-title":"European Respiratory Journal"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0846-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0846-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0846-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T19:08:04Z","timestamp":1588360084000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0846-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0846-2","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"1 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Registry has ethical approval to operate in all States and Territories of Australia. All participants provide informed written consent to have their data collected and entered into the Registry. This analysis has ethical approval from the Sydney Local Health District ethics committee (protocol No X14\u20130264) to utilise de-identified data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"84"}}